アッヴィ株式会社
MX ˙ BMV ˙ US00287Y1091
SecurityMX:ABBV / AbbVie Inc.
InstitutionPerkins Capital Management Inc
Latest Disclosed Ownership5,342 shares
Latest Disclosed Value $ 1,161,831
Perkins Capital Management Inc reports 8.56% decrease in ownership of ABBV / AbbVie Inc.

On April 23, 2026 - Perkins Capital Management Inc filed a 13F-HR form disclosing ownership of 5,342 shares of AbbVie Inc. (MX:ABBV) valued at $1,161,831 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 4, 2026 disclosing 5,842 shares of AbbVie Inc.. This represents a change in shares of -8.56% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-23 2026-03-31 13F ABBVIE COM 00287Y109 5,342 -500 -8.56 1,162 -12.97 1.0889
2026-02-04 2025-12-31 13F ABBVIE COM 00287Y109 5,842 0 0.00 1,335 -1.33 1.0599
2025-10-31 2025-09-30 13F ABBVIE COM 00287Y109 5,842 -50 -0.85 1,353 23.70 1.1921
2025-08-07 2025-06-30 13F AbbVie COM 00287Y109 5,892 -338 -5.43 1,094 -16.25 1.0996
2025-05-07 2025-03-31 13F ABBVIE COM 00287Y109 6,230 -78 -1.24 1,305 16.52 1.3764
2025-02-11 2024-12-31 13F ABBVIE COM 00287Y109 6,308 -250 -3.81 1,121 -13.51 0.9944
2024-10-31 2024-09-30 13F ABBVIE COM 00287Y109 6,558 -1,425 -17.85 1,295 129,400.00 1.2145
2024-08-09 2024-06-30 13F ABBVIE COM 00287Y109 7,983 -525 -6.17 1 0.00 1.2899
2024-05-09 2024-03-31 13F ABBVIE COM 00287Y109 8,508 -650 -7.10 2 0.00 1.2917
2024-01-22 2023-12-31 13F ABBVIE COM 00287Y109 9,158 -1,700 -15.66 1 0.00 1.2120
2023-11-02 2023-09-30 13F AbbVie COM 00287Y109 10,858 -150 -1.36 2 0.00 1.6040
2023-07-21 2023-06-30 13F ABBVIE COM 00287Y109 11,008 -500 -4.34 1 0.00 1.2923
2023-05-09 2023-03-31 13F ABBVIE COM 00287Y109 11,508 -100 -0.86 2 0.00 1.7292
2023-01-26 2022-12-31 13F ABBVIE COM 00287Y109 11,608 0 0.00 2 -99.94 1.9804
2022-10-24 2022-09-30 13F ABBVIE COM 00287Y109 11,608 -417 -3.47 1,558 -15.42 1.7433
2022-07-29 2022-06-30 13F ABBVIE COM 00287Y109 12,025 0 0.00 1,842 -5.49 1.9067
2022-04-20 2022-03-31 13F ABBVIE COM 00287Y109 12,025 0 0.00 1,949 19.72 1.5978
2022-02-10 2021-12-31 13F ABBVIE COM 00287Y109 12,025 -288 -2.34 1,628 22.59 1.0990
2021-10-25 2021-09-30 13F ABBVIE COM 00287Y109 12,313 0 0.00 1,328 -4.25 0.8221
2021-07-28 2021-06-30 13F ABBVIE COM 00287Y109 12,313 0 0.00 1,387 4.05 0.7870
2021-04-28 2021-03-31 13F ABBVIE COM 00287Y109 12,313 125 1.03 1,333 2.07 0.7709
2021-02-09 2020-12-31 13F ABBVIE COM 00287Y109 12,188 -900 -6.88 1,306 13.96 0.8541
2020-10-28 2020-09-30 13F ABBVIE COM 00287Y109 13,088 -1,250 -8.72 1,146 4.95 1.0526
2020-04-29 2020-03-31 13F ABBVIE COM 00287Y109 14,338 -200 -1.38 1,092 -15.15 1.3192
2020-02-03 2019-12-31 13F ABBVIE COM 00287Y109 14,538 -2,450 -14.42 1,287 0.08 1.1538
2019-10-23 2019-09-30 13F ABBVIE COM 00287Y109 16,988 6,038 55.14 1,286 61.56 1.1080
2019-08-09 2019-06-30 13F ABBVIE COM 00287Y109 10,950 200 1.86 796 -8.08 0.5574
2019-04-22 2019-03-31 13F ABBVIE COM 00287Y109 10,750 10,750 866 0.5702
2018-04-23 2018-03-31 13F ABBVIE COM 00287Y109 0 -20,300 -100.00 0 -100.00
2018-01-26 2017-12-31 13F ABBVIE COM 00287Y109 20,300 750 3.84 1,963 13.01 1.8876
2017-10-31 2017-09-30 13F ABBVIE COM 00287Y109 19,550 -100 -0.51 1,737 21.89 1.8199
2017-07-26 2017-06-30 13F ABBVIE COM 00287Y109 19,650 -25 -0.13 1,425 11.15 1.5803
2017-04-19 2017-03-31 13F ABBVIE COM 00287Y109 19,675 2,150 12.27 1,282 16.86 1.3227
2017-02-01 2016-12-31 13F ABBVIE COM 00287Y109 17,525 -250 -1.41 1,097 -2.14 1.2027
2016-11-04 2016-09-30 13F ABBVIE COM 00287Y109 17,775 300 1.72 1,121 3.60 1.1208
2016-07-20 2016-06-30 13F ABBVIE COM 00287Y109 17,475 -1,000 -5.41 1,082 2.56 1.2404
2016-04-18 2016-03-31 13F ABBVIE COM 00287Y109 18,475 0 0.00 1,055 -3.56 1.3206
2016-01-28 2015-12-31 13F ABBVIE COM 00287Y109 18,475 -100 -0.54 1,094 8.21 1.1739
2015-11-09 2015-09-30 13F ABBVIE COM 00287Y109 18,575 750 4.21 1,011 -15.61 1.1248
2015-07-29 2015-06-30 13F ABBVIE COM 00287Y109 17,825 -50 -0.28 1,198 14.53 1.0521
2015-04-28 2015-03-31 13F ABBVIE COM 00287Y109 17,875 100 0.56 1,046 -10.06 0.8768
2015-02-13 2014-12-31 13F ABBVIE COM 00287Y109 17,775 900 5.33 1,163 19.28 0.9981
2014-11-14 2014-09-30 13F ABBVIE COM 00287Y109 16,875 16,875 975 0.8240
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.